Pediatric ethics
Executive Summary
FDA's Pediatric Advisory Subcommittee on Pediatric Ethics will meet June 9-10 to discuss clinical investigations that involve greater than minimal risk but present the prospect of direct benefits to individual subjects. The June 9 discussion will be illustrated with hypothetical cases of research involving HIV vaccines in adolescents and controlled trials of inhaled corticosteroids in children with asthma, and the June 10 discussion with a hypothetical case of research using stem cells for treating periventricular white matter injury in children